Pharmaids [PHARMAID] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Pharmaids Pharmaceuticals Limited

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pharmaids Pharmaceuticals Limited wins in 4 metrics, Divi's Laboratories Ltd. wins in 14 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Pharmaids Pharmaceuticals Limited Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 2,023.33 67.11 Divi's Laboratories Ltd.
Price-to-Book Ratio 2.11 10.82 Pharmaids Pharmaceuticals Limited
Debt-to-Equity Ratio 39.24 0.58 Divi's Laboratories Ltd.
PEG Ratio 74.19 4.63 Divi's Laboratories Ltd.
EV/EBITDA -7.84 48.63 Divi's Laboratories Ltd.
Profit Margin (TTM) -54.23% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) -54.88% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) N/A 29.65% N/A
Return on Equity -19.58% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) -8.99% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-264.72M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -50.97% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 4.28 16.18 Pharmaids Pharmaceuticals Limited
Enterprise Value $1.29B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 5.05 15.86 Pharmaids Pharmaceuticals Limited
Gross Profit Margin (TTM) 56.76% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $7 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $-5.13 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.06 0.19 Pharmaids Pharmaceuticals Limited

Pharmaids Pharmaceuticals Limited vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

PHARMAID
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Pharmaids Pharmaceuticals Limited-1.88%-2.05%-8.42%-22.03%-45.59%-43.03%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Pharmaids Pharmaceuticals Limited-50.97%1.30%33.07%991.37%692.17%205.54%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Pharmaids Pharmaceuticals Limited vs Divi's Laboratories Ltd.

MetricPHARMAIDDIVISLAB
Market Information
Market Cap i₹1.09B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,801253,443
90 Day Avg. Volume i13,247283,911
Last Close₹27.18₹6,576.50
52 Week Range₹25.60 - ₹70.00₹5,636.50 - ₹7,071.50
% from 52W High-61.17%-7.00%
All-Time High₹87.46 (Nov 11, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-68.92%-7.00%
Growth Metrics
Quarterly Revenue Growth0.15%0.12%
Quarterly Earnings Growth0.15%-0.01%
Financial Health
Profit Margin (TTM) i-0.54%0.24%
Operating Margin (TTM) i-0.55%0.30%
Return on Equity (TTM) i-0.20%0.15%
Debt to Equity (MRQ) i39.240.58
Cash & Liquidity
Book Value per Share (MRQ)₹14.65₹580.95
Cash per Share (MRQ)₹0.07₹122.95
Operating Cash Flow (TTM) i₹-278,094,000₹19.67B
Levered Free Cash Flow (TTM) i₹-107,766,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Pharmaids Pharmaceuticals Limited vs Divi's Laboratories Ltd.

MetricPHARMAID (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i2,023.3367.11
Forward P/E iN/A53.75
PEG Ratio i74.194.63
Price to Sales (TTM) i4.2816.18
Price to Book (MRQ) i2.1110.82
Market Capitalization
Market Capitalization i₹1.09B₹1.69T
Enterprise Value i₹1.29B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i5.0515.86
Enterprise to EBITDA i-7.8448.63
Risk & Other Metrics
Beta i0.060.19
Book Value per Share (MRQ) i₹14.65₹580.95

Financial Statements Comparison: Pharmaids Pharmaceuticals Limited vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPHARMAID (2025)DIVISLAB (2025)
Revenue/Sales i188.13M93.25B
Cost of Goods Sold i142.75M38.70B
COGS % of Revenue i75.9%41.5%
Gross Profit i45.38M54.55B
Gross Margin i24.1%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i-151.64M25.71B
Operating Margin i-80.6%27.6%
EBITDA i-127.33M33.19B
EBITDA Margin i-67.7%35.6%
Pre-Tax Income i-172.79M29.16B
Pre-Tax Income % of Revenue i-91.8%31.3%
Income Tax i-37.74M7.25B
Income Tax % of Revenue i-20.1%7.8%
Net Income (Profit) i-135.05M21.91B
Profit Margin i-71.8%23.5%

Balance Sheet & Liquidity Metrics

MetricPHARMAID (2025)DIVISLAB (2025)
Cash & Equivalents i21.45M4.15B
Total Current Assets i223.07M100.81B
Total Current Assets % of Revenue i118.6%108.1%
Total Current Liabilities i287.15M14.52B
Total Current Liabilities % of Revenue i152.6%15.6%
Long-Term Debt i331.19M20.00M
Long-Term Debt % of Revenue i176.0%0.0%
Total Shareholders Equity i550.42M149.69B
Retained Earnings i-266.77M134.00B
Retained Earnings % of Revenue i-141.8%143.7%
Property, Plant & Equipment i19.32M3.19B

Cash Flow Statement Comparison

MetricPHARMAID (2025)DIVISLAB (2025)
Operating Cash Flow i-278.09M19.67B
Operating Cash Flow % of Revenue i-147.8%21.1%
Capital Expenditures i-122.62M-14.38B
Free Cash Flow i-264.72M2.15B
FCF Margin i-140.7%2.3%
Debt Repayment i-49.10MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPHARMAIDDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i35.27M265.47M
Float Shares i6.95M117.72M
% Held by Insiders i83.97%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i16.03%19.31%

Dividend Analysis & Yield Comparison: Pharmaids Pharmaceuticals Limited vs Divi's Laboratories Ltd.

MetricPHARMAIDDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025